PAS
VERA icon

Point72 Asia (Singapore)’s Vera Therapeutics VERA Stock Holding History

Point72 Asia (Singapore)’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,407
Closed -$416K – 1242
2024
Q3 		$416K Buy
9,407
+4,914
+109% +$186K 0.08% 208
2024
Q2 		$163K Buy
+4,493
New +$178K 0.03% 352

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Point72 Asia (Singapore)'s VERA Position: Q4 2024 in Review

Point72 Asia (Singapore) sold out of Vera Therapeutics (VERA) in Q4 2024, closing a stake of 9,407 shares — an estimated $416K sold.

Point72 Asia (Singapore) first reported a position in VERA in Q2 2024 and held it in 2 quarters. The position peaked at $416K in Q3 2024. 178 funds tracked by Wall St. Rank hold VERA as of Q4 2024.

  • Point72 Asia (Singapore) reported no remaining Vera Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 9,407 Vera Therapeutics shares in Q4 2024, an estimated $416K.
  • Point72 Asia (Singapore) first reported a position in Vera Therapeutics in Q2 2024 and held it in 2 quarters.
  • Point72 Asia (Singapore)'s Vera Therapeutics position peaked at $416K in Q3 2024.
  • 178 funds tracked by Wall St. Rank held Vera Therapeutics as of Q4 2024.

Based on Point72 Asia (Singapore)'s 13F filing for Q4 2024, filed 14 Feb 2025.